A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Since activation, 3 subjects were enrolled but were ineligible for randomization to a treatment arm because of a positive diagnostic laparoscopy result. Given the repeat inability to enroll and randomize an eligible subject; accrual was halted.

Conditions

Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Docetaxel
BIOLOGICAL: GSCF

Sponsor

Baylor College of Medicine